Page last updated: 2024-09-05

glycitin and Lung Injury, Acute

glycitin has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Y; Guo, M; Guo, S; Jiang, K; Wang, Y; Yang, M	1

Other Studies

1 other study(ies) available for glycitin and Lung Injury, Acute

Article	Year
Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice. International immunopharmacology, 2019, Volume: 75 Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; HEK293 Cells; Humans; Isoflavones; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neutrophils; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4	2019

Article

Year

Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice.

International immunopharmacology, 2019, Volume: 75

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; HEK293 Cells; Humans; Isoflavones; Lipopolysaccharides; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neutrophils; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4

2019